INOZYME PHARMA INC. -
5.2100
07-أكتوبر-24 15:59:31
15 متأخرة بدقائق
الأسهم
+0.0400
+0.77%
نطاق اليوم
5.1200 - 5.2800
ISIN
N/A
المصدر
NASDAQ
-
Inozyme Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 مايو 2023 08:30:00 بحسب Nasdaq GlobeNewswire
-
14 أبريل 2023 08:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma to Participate at the 22nd Annual Needham Virtual Healthcare Conference
11 أبريل 2023 08:30:00 بحسب Nasdaq GlobeNewswire
-
04 أبريل 2023 08:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Full Year 2022 Financial Results and Provides Business Highlights
22 مارس 2023 08:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma to Participate in the Cowen 43rd Annual Health Care Conference
01 مارس 2023 08:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Positive Topline Data from Ongoing Phase 1/2 Trials of INZ-701
16 فبراير 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma to Host Virtual Investor and Analyst Event on Feb. 16, 2023
06 فبراير 2023 07:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Announces Investor and Analyst Event and Highlights 2022 Progress
09 يناير 2023 08:30:00 بحسب Nasdaq GlobeNewswire
-
05 ديسمبر 2022 08:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma to Participate at the BofA Securities Biotech SMID Cap Conference
01 ديسمبر 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Third Quarter 2022 Financial Results and Provides Business Updates
10 نوفمبر 2022 08:30:01 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma to Participate in Upcoming Investor Conferences
07 نوفمبر 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
03 نوفمبر 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Announces Publication of Comprehensive ENPP1 Variant Database
31 أكتوبر 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma to Present at H.C. Wainwright 24th Annual Global Investment Conference
06 سبتمبر 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Second Quarter 2022 Financial Results and Provides Business Updates
15 أغسطس 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
Inozyme Pharma Secures Flexible Debt Facility for up to $70 Million with K2 HealthVentures
26 يوليو 2022 07:30:00 بحسب Nasdaq GlobeNewswire
-
19 يوليو 2022 16:30:00 بحسب Nasdaq GlobeNewswire
-
16 يونيو 2022 07:30:00 بحسب Nasdaq GlobeNewswire